Page last updated: 2024-08-23

epirubicin and Gasser Syndrome

epirubicin has been researched along with Gasser Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ackland, SP; Deveridge, S; van der Heijden, M1
Burian, M; Czerny, C; Formanek, M; Kletzmayr, J; Kornek, G; Quint, C; Thurnher, D1
Bruckner, HW; Kozuch, P; Petryk, M1

Reviews

2 review(s) available for epirubicin and Gasser Syndrome

ArticleYear
Haemolytic uraemic syndrome associated with bleomycin, epirubicin and cisplatin chemotherapy--a case report and review of the literature.
    Acta oncologica (Stockholm, Sweden), 1998, Volume: 37, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Epirubicin; Female; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Nasopharyngeal Neoplasms

1998
A comprehensive update on the use of chemotherapy for metastatic pancreatic adenocarcinoma.
    Hematology/oncology clinics of North America, 2002, Volume: 16, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Camptothecin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Deoxycytidine; Docetaxel; Enzyme Inhibitors; Epirubicin; Fluorouracil; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Interferon alpha-2; Interferon-alpha; Irinotecan; Leucovorin; Multicenter Studies as Topic; Organoplatinum Compounds; Paclitaxel; Palliative Care; Pancreatic Neoplasms; Recombinant Proteins; Respiratory Distress Syndrome; Taxoids; Treatment Outcome

2002

Other Studies

1 other study(ies) available for epirubicin and Gasser Syndrome

ArticleYear
Chemotherapy-related hemolytic-uremic syndrome following treatment of a carcinoma of the nasopharynx.
    Oncology, 2001, Volume: 61, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cortisone; Epirubicin; Fatal Outcome; Female; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Nasopharyngeal Neoplasms; Plasma; Plasma Exchange; Renal Dialysis

2001